Business

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

CHICAGO, IL / ACCESSWIRE / February 7, 2023 / Cosmos Health Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of

articleCosmos Health Inc.February 7, 20234/company/cosmos-health-inc/news/cosmos-health-announces-initial-purchase-order-with-virax-biolabs-for-the-distribution-of-covid-19-and-influenza-ab-antigen-combo-rapid-tests
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

About this update from Cosmos Health Inc.

[{"type":"text","content":"CHICAGO, IL / ACCESSWIRE / February 7, 2023 / Cosmos Health Inc. (\"the Company\") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the first purchase order to market and distribute Virax Biolabs' (Nasdaq: VRAX) ViraxClear branded COVID-19 and Influenza A+B Antigen Combo Rapid Detection Kits. Pursuant to its previously signed distribution agreement dated September 2022, Cosmos Health will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the ViraxClear branded test kits across Europe on a non-exclusive basis.The COVID-19 & Influenza A+B antigen combo rapid test is a single-use test kit intended for qualitative detection of nucleocapsid protein antigen of Influenza A and B viral antigens and COVID-19 antigen from nasal swab specimens.Greg Siokas, Chief Executive Officer of Cosmos Health stated: \"We are excited to partner with Virax to bring much needed dual testing solutions to Greece and Cyprus as well as expanding into additional territories going forward. Our customers are indicating a strong demand for fast and conducive testing methods for COVID-19 and Influenza A+B, as these viruses continue to threaten lives across the world. We expect that our success in Greece and Cyprus will allow us to enter larger Europeans countries. Our agreement with Virax is yet another example of Cosmos Health's vision to become the distributor of unique and innovative products globally. Furthermore, we are pleased with our solid balance sheet, as it continues to be instrumental in our ability to form relationships with reputable companies such as Virax.\"About Cosmos Health, Inc.Cosmos Health Inc. (Nasdaq: COSM) is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products \"Sky Premium Life\" and \"Mediterranation.\" Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Healt...

More updates from Cosmos Health Inc.